Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The subscription period in Audientes A/S’s rights issue of units begins today

Company announcement no. 31-2022December 1, 2022 Today, 1 December 2022, is the first day of the subscription period in Audientes A/S (CVR. No. 36 04 76 31) pre-emptive rights issue of units (the “Rights Issue”). The public is also invited to subscribe for units in the Rights Issue. The subscription period runs until, and including, 15 December 2022. The Rights Issue can initially provide the Company with approx. DKK 14 million before deduction of transaction related costs. In March/April 2023, Audientes can be provided with an additional maximum amount of approx. DKK 10.3 million before

BioStock: Curasight eagerly awaiting phase II-results in brain cancer

Looking back at the time since Curasight first IPO’ed two years ago, CEO Ulrich Krasilnikoff sees a period where a lot has happened. With positive phase II results in several cancer indications for drug candidate uTRACE the company is now eagerly awaiting yet another set of results from the study in brain cancer. BioStock has contacted Krasilnikoff to learn more about the recently released Q3 report and what lies ahead for the company.Read the full article at biostock.se: https://www.biostock.se/en/2022/12/curasight-eagerly-awaiting-phase-ii-results-in-brain-cancer/ This is a press

Cereno Scientific participates at the 19th Global CVCT Forum 2022 discussing clinical trials in cardiovascular disease with top thought leaders

Cereno Scientific (XSAT: CRNO B) today announced the company will participate at the 19th Global CVCT Forum 2022 on December 1-3, 2022, in Washington D.C., US. The Global Cardiovascular Clinical Trialists (CVCT) Forum brings together the top thought leaders in cardiovascular disease and is co-chaired by Dr Bertram Pitt and Dr Faiez Zannad, both part of Cereno’s Scientific Advisory Board. Cereno’s Chief Medical Officer (CMO), Dr Björn Dahlöf, is invited to speak and participate in several program sessions providing an industry perspective on significant topics such as patient benefit, clinical

Discover Coloreel’s embroidery on-demand at Gina Tricot’s flagship Store

Coloreel has partnered with Gina Tricot to offer a unique chance to personalize new and loved clothing with Coloreel’s unlimited color embroidery technology.As a part of their Creative Studio initiative to offer more fun and sustainable ways for customers to stay on-trend with up-cycling and personalization, the Swedish fashion brand Gina Tricot will launch an on-demand embroidery studio in their Borås flagship store. During the first week of December, Coloreel will install one of its instant thread coloring units at Gina Tricot in Pallashuset. Customers can choose their favorite design

Outokumpu – Announcement regarding change in holdings

Outokumpu OyjStock exchange releaseDecember 1, 2022 at 10.00 am EETOutokumpu – Announcement regarding change in holdings Outokumpu Oyj (business identity code: 0215254-2) has on November 30, 2022 received a notification based on Chapter 9, Section 5 of the Finnish Securities Market Act. Société Générale SA’s total holding in the shares and voting rights of Outokumpu has risen above 5% threshold and was 5.62% on November 29, 2022. Their earlier holding in the Outokumpu shares and voting rights was below minimum threshold.   +----------------+----------+------------------+--------

Epiroc presents world’s first underground mine truck made using fossil-free steel from SSAB

Epiroc is pioneering a battery-electric underground mine truck prototype made using fossil-free steel from SSAB. The prototype, a Minetruck MT42 Battery, has a dump box made from fossil-free steel. The result will mean a 10-tonne reduction in CO2 emissions per manufactured dump box, the equivalent of taking five gasoline cars off the road for an entire year. “The development of new technologies is essential to enable the transition to a low-carbon economy,” says Johnny Sjöström, head of SSAB Special Steels. “Our fossil-free steel immediately reduces the carbon footprint to near

Aptahem’s CEO interviewed during the Biotechgate conference

Mikael Lindstam, CEO at Aptahem, was interviewed during the Biotechgate digital partnering conference. In the video he describes the development process with the company’s lead candidate Apta-1, from discovery, through manufacturing and preclinical studies up to clinical phase. The interview also explains why Apta-1 is thought to be a potential drug candidate for sepsis.Watch the interview with Aptahem's CEO Mikael Lindstam by following the link below: https://youtu.be/LthryhUCxjE For further information: Aptahem ABMikael Lindstam, CEOTel: +46 (0)766-33 36 99E-mail: ml@

Can Nordic companies extend the life of Keytruda?

Merck’s cancer drug Keytruda is one of the best-selling drugs in the world right now. But with the main patent expiring in 2028, the pharmaceutical giant has begun to review its strategy to maintain its top spot on the oncology market. BioStock has taken a closer look at the history of Keytruda, what lies ahead and what that means for biotech companies in the Nordic region.Read the full article at biostock.se: https://www.biostock.se/en/2022/12/can-nordic-companies-extend-the-life-of-keytruda/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Invitation to presentation of Sectra’s six-month interim report 2022/2023 and date for CMD 2023

Linköping, Sweden – December 1, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will host a presentation of the company’s six-month report 2022/2023 with President Torbjörn Kronander and CFO Jessica Holmquist. Sectra will also hold a Capital Markets Day (CMD) on January 27, 2023.Publication of the financial report: 8:15 a.m. (CET) on December 16, 2022Report presentation: 10:00 a.m. (CET) on the same date Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions

Offer document regarding the offer to the shareholders of AdderaCare made public

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR THE UNITED STATES (THE ”RESTRICTED JURISDICTIONS”), OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE

Epiroc completes acquisition of leading provider of mining automation solutions

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has completed the acquisition of Remote Control Technologies Pty Ltd, an Australian company that provides automation and remote-control solutions for mining customers around the world. With this acquisition, Epiroc will be the world-leading automation solutions provider not only for surface and underground rock drilling but also for underground loading and haulage.Remote Control Technologies, known as RCT, is headquartered in Perth, Australia, with customers in more

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions  1.12.2022 at 9.30Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Veli-Matti  ReinikkalaPosition: Member of the Board/Deputy member Issuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 21649/7/6____________________________________________ Transaction date: 2022-11-29Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of the

Veg of Lund signs agreement for production of DUG in Germany

Veg of Lund AB has signed an agreement with an established European processing and packaging company for the production of the company’s potato beverage, sold under the DUG brand. Commercial production is expected to start in February 2023.Veg of Lund has signed an agreement with a European player for the production of its plant-based drink DUG for Sweden and neighbouring markets. The production will take place in northern Germany and will complement existing production in England, which will mainly supply the UK and Irish markets.  “We have signed an agreement with an established

Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer

Bringing more than 20 years of experience as a senior level executive in the global pharmaceutical and biotech industry, Francois Martelet will join Scandion Oncology on January 2, 2023.Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, announces that the company’s Board of Directors has appointed Francois Martelet as new Chief Executive Officer (CEO). Francois will take up his new position on January 2, 2023. Trained as a Medical Doctor with a Master’s degree in Business, Francois

Interim report May – Oct 2022: Continued steady growth shows that we are on track to establish OPRA[TM] in the US

The period AUG 1st 2022 – Oct 31st 2022 ▪    Net sales amountedTSEK 20 226 (11 883), which is an increase of 70% compared with the corresponding period last year. The growth in the US market is 78% compared with the corresponding period last year. ▪    Operating profit amounted to TSEK 873 (-243) ▪    Net profit amounted to TSEK 2 320 (16 186) ▪    Cashflow from operating activities amounted to TSEK -1 032 (1 238) ▪    Earnings per share amounted to 0,13 SEK (0.90) Significant events in the quarter ▪    The number of hospitals offering the treatment continue to increase.

BioStock: CombiGene’s CEO on the FDA approval of Hemgenix

As gene therapies advance through clinical trials, more and more of these treatments are receiving approval from the U.S. Food and Drug Administration and its European counterpart, the European Medicines Agency. The latest in line to gain approval by the FDA was CSL Behring’s hemophilia B gene therapy Hemgenix. With a price tag of 3.5 MUSD per dose, Hemgenix will be the most expensive medicine in the world. BioStock reached out to Jan Nilsson, CEO of the Swedish gene therapy company CombiGene, for a comment.Read the full interview with CombiGene's CEO Jan Nilsson at biostock.se: https://

Nowhere Networks closes world’s largest deal ever in maritime high-speed internet communication as Stena Line chooses its solution for 32 of its ships

Stena Line, one of the world’s largest ferry operators with over 25,000 yearly departures, has chosen Nowhere Networks as its supplier of fast internet for its fleet. Implementation has started and by the beginning of next year 32 of Stena Line’s ships will be connected to Nowhere Networks high speed internet Network. The total distance of the routes covered will be approximately 4000 km, the largest network of its kind in the world.Stena Line has been in the market to procure a faster and more reliable high speed wifi-solution to offer its passengers and employees on board. As everything

Electrolux Professional Group top performer in its industry in ESG risk-ranking

Electrolux Professional Group has been rated as the top performer among its listed, ranked, competitors by Sustainalytics, a Morningstar Company, which ranks the environmental, social, and corporate governance (ESG) performance of over 14,000 companies worldwide.In achieving the ‘low’ ESG risk-rating, Electrolux Professional Group’s performance results in a #1 ranking among listed, ranked competitors in its industry, and #3 out of the 558 companies ranked in the Machinery industry. “We are very proud to have received this feedback on our performance with a low ESG risk-rating from

Inside information: Delete Group initiates a strategic evaluation to support the Company's growth

Delete Group Oyj            Stock exchange release       1 December 2022 at 9:00 a.m. EET Inside informationInside information: Delete Group initiates a strategic evaluation to support the Company's growth The Board of Directors of Delete Group Oyj (“Delete” or the “Company”) and funds managed by Axcel Management A/S, the ultimate majority shareholder of the Company, have decided to initiate a strategic evaluation to further support the Company's strategy implementation and accelerate growth. One potential result of the strategic evaluation is the sale of the Company and its Cleaning

Caverion acquires Carrier's food retail refrigeration business in Finland and further expands its food retail solutions offering

Caverion Corporation Investor News 1 December 2022 at 09.00 a.m. EETCaverion acquires Carrier's food retail refrigeration business in Finland and further expands its food retail solutions offering Caverion acquires Carrier's commercial refrigeration projects and related services business in Finland and expands its food retail refrigeration offering. The acquisition was closed today.   The transaction will further strengthen Caverion's refrigeration business and expertise and will bring Carrier's market-leading food retail refrigeration product portfolio to Caverion’s

Switzerland’s fastest-growing AI company Unit8 takes a look at the Swiss economy in 2023

According to Unit8, Swiss companies are preparing for tougher times: costs and processes are under scrutiny, including spending on IT infrastructure, cloud technologies, and AI & analytics initiatives.Nevertheless, with AI & analytics’s vast potential in delivering efficiency gains across an organisation’s value chain, AI & analytics should not be seen as a cost to be mitigated but rather as a strategic response to the incoming economic headwinds. (Zurich) As an AI company operating throughout Switzerland, Unit8 gains insights into the challenges Swiss companies are struggling with on a

Timo Leinonen will commence as CFO of Oriola on 1 December 2022

Oriola Corporation Investor news 1 December 2022 at 9 a.m. Timo Leinonen will commence as CFO of Oriola on 1 December 2022 Oriola announced on 19 July 2022 in a stock exchange release that Timo Leinonen, M. Sc. (Admin), will start as Oriola Corporation’s Chief Financial Officer (CFO) at the latest January 2023. The date has now been confirmed and he will commence his new role on 1 December 2022. As communicated in the earlier stock exchange release, Leinonen is joining Oriola from StaffPoint, where he has been working as CFO since 2018. Further information: Mikael WegmüllerVP,

Faron Appoints Maija Hollmén PhD as CSO

Faron Pharmaceuticals Ltd. (“Faron or “Company”)   Faron Appoints Maija Hollmén, Ph.D., as Chief Scientific Officer   Company announcement, December 1, 2022, at 02:00 AM (EST) / 07:00 AM (GMT) / 09:00 AM (EET)   TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling difficult-to-treat cancers and inflammation via precision macrophage immunotherapy, today announces the appointment of Faron Co-founder Maija Hollmén, Ph.D., as Chief Scientific Officer.   In her new role,

Metso Outotec to supply copper solvent extraction and electrowinning technology to Kazakhstan

Metso Outotec Corporation press release, December 1, 2022, at 9:00 am EETMetso Outotec has signed an agreement with Kyzyl Aray Copper, a subsidiary of Caravan Resources, for the supply of copper solvent extraction and electrowinning technology for a plant to be built in the Karagandy region of the Republic of Kazakhstan. The order of approximately EUR 35 million has been booked in the Minerals segment’s fourth-quarter order intake. The Metso Outotec technology package delivery includes the modular VSF[®]X solvent extraction plant and the main process equipment for the electrowinning

There are no items matching the current filter
There are no more items matching the current filter
Back to top